Medi-first Plus Non-aspirin Tablet, Coated
NDC Package 47682-059-48
Package Information
Medi-first Plus Non-aspirin (acetaminophen) tablets is a medication used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever. This formulation utilizes a tablet, coated delivery system. Marketed by Unifirst First Aid Corporation, this product is identified by NDC 47682-059 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 313782 - acetaminophen 325 MG Oral Tablet
- RxCUI: 313782 - APAP 325 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 47682 - Unifirst First Aid Corporation
- 47682-059 - Medi-first Plus Non-aspirin
- 47682-059-48 - 125 PACKET in 1 BOX / 2 TABLET, COATED in 1 PACKET
- 47682-059 - Medi-first Plus Non-aspirin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (47682-059). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 47682-059-48 identifies a specific commercial package of 125 packet in 1 box / 2 tablet, coated in 1 packet of Medi-first Plus Non-aspirin, a human over the counter drug labeled by Unifirst First Aid Corporation. This tablet, coated is formulated for oral use and contains acetaminophen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Unifirst First Aid Corporation on March 27, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This drug is used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever.
How is this Unifirst First Aid Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 47682005948. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.